High titres of autoantibodies to glutamic acid decarboxylase (GAD), the rate-limiting enzyme in the synthesis of the inhibitory neurotransmitter gamma-amino butyric acid (GABA), have been reported in approximately 60–80 % of patients with classic SPS [3]. Here, GAD1 is linked to stiff-person syndrome.